Acute coronary syndrome and depression: A review of shared pathophysiological pathways

Australian and New Zealand Journal of Psychiatry

Volumn 49, Issue 11, 2015, Pages 994-1005

  Granville Smith, Isabelle ^a   Parker, Gordon ^a   Rourke, Poppy ^a   Cvejic, Erin ^a   Vollmer Conna, Uté ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

acute coronary syndrome; autonomic nervous system; biological mechanisms; Depression; inflammatory response

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; GLUCOCORTICOID; INDOLEAMINE 2,3 DIOXYGENASE; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEROTONIN UPTAKE INHIBITOR; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; AUTONOMIC NERVOUS SYSTEM; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM; HEART RATE VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE; MENTAL STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SEROTONINERGIC TRANSMISSION; SYSTEMATIC REVIEW; THROMBOCYTE FUNCTION; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION; ALTERNATIVE MEDICINE; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; PATHOPHYSIOLOGY;

ACUTE CORONARY SYNDROME; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; MIND-BODY RELATIONS, METAPHYSICAL;

EID: 84945963823     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867415597304     Document Type: Review

References (147)

1. Aaronson ST, Carpenter LL, Conway CR, et al. (2012) Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: Acute, and chronic effects. Brain Stimulation 6: 631-640
2. Andersson U, and Tracey KJ. (2012). Reflex principles of immunological homeostasis. Annual Review of Immunology 30: 313-335
3. Antoniades C, Shirodaria C, Crabtree M, et al. (2007) Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation. Circulation 116: 2851-2859
4. Aslakson E, Vollmer-Conna U, Reeves WC, et al. (2009) Replication of an empirical approach to delineate the heterogeneity of chronic unexplained fatigue. Population Health Metrics 7: 17-27
5. Baune BT, Stuart M, Gilmour A, et al. (2012) The relationship between subtypes of depression, and cardiovascular disease: A systematic review of biological models. Translational Psychiatry 2: e92
6. Beaumont A, Burton AR, Lemon J, et al. (2012) Reduced cardiac vagal modulation impacts on cognitive performance in chronic fatigue syndrome. PLoS ONE 7: e49518
7. Bendall JK, Douglas G, McNeill E, et al. (2013) Tetrahydrobiopterin in cardiovascular health, and disease. Antioxidants, and Redox Signaling 20: 3040-3077
8. Broadley AJ, Korszun A, Abdelaal E, et al. (2005) Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction, and baroreflex impairment. Journal of the American College of Cardiology 46: 344-350
9. Brown DW, Giles WH, and Croft JB. (2001). White blood cell count: An independent predictor of coronary heart disease mortality among a national cohort. Journal of Clinical Epidemiology 54: 316-322
10. Brull D, Serrano N, Zito F, et al. (2003) Human CRP gene polymorphism influences CRP levels implications for the prediction, and pathogenesis of coronary heart disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23: 2063-2069
11. Burg MM, Edmondson D, Shimbo D, et al. (2013) The perfect storm, and acute coronary syndrome onset: Do psychosocial factors play a role? Progress in Cardiovascular Diseases 55: 601-610
12. Burg MM, Martens EJ, Collins D, et al. (2011) Depression predicts elevated endothelin-1 in patients with coronary artery disease. Psychosomatic Medicine 73: 2-6
13. Capuron L, Neurauter G, Musselman DL, et al. (2003) Interferon-Alphainduced changes in tryptophan metabolism: Relationship to depression, and paroxetine treatment. Biological Psychiatry 54: 906-914
14. Capuron L, Raison CL, Musselman DL, et al. (2003) Association of exaggerated HPA axis response to the initial injection of interferonalpha with development of depression during interferon-Alpha therapy. American Journal of Psychiatry 160: 1342-1345
15. Carney RM, Blumenthal JA, Freedland KE, et al. (2004) Depression, and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosomatic Medicine 66: 466-474
16. Carney RM, Blumenthal JA, Stein PK, et al. (2001) Depression, heart rate variability, and acute myocardial infarction. Circulation 104: 2024-2028
17. Carney RM, Freedland KE, Stein PK, et al. (2007) Heart rate variability, and markers of inflammation, and coagulation in depressed patients with coronary heart disease. Journal of Psychosomatic Research 62: 463-467
18. Catena-DellOsso M, Rotella F, DellOsso A, et al. (2013) Inflammation, serotonin, and major depression. Current Drug Targets 14: 571-577
19. Chalikias GK, Tziakas DN, Kaski JC, et al. (2005) Interleukin-18: Interleukin-10 ratio, and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis 182: 135-143
20. Cirillo P, Cimmino G, DAiuto E, et al. (2014) Local cytokine production in patients with acute coronary syndromes: A look into the eye of the perfect (cytokine) storm. International Journal of Cardiology 176: 227-229
21. Cote F, Fligny C, Fromes Y, et al. (2004) Recent advances in understanding serotonin regulation of cardiovascular function. Trends in Molecular Medicine 10: 232-238
22. Cowan MJ, Freedland KE, Burg MM, et al. (2008) Predictors of treatment response for depression, and inadequate social support-The ENRICHD randomized clinical trial. Psychotherapy, and Psychosomatics 77: 27-37
23. Dalziel B, Gosby AK, Richman RM, et al. (2002) Association of the TNFalpha-308 G/A promoter polymorphism with insulin resistance in obesity. Obesity Research 10: 401-407
24. Dantzer R, OConnor JC, Freund GG, et al. (2008) From inflammation to sickness, and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience 9: 45-56
25. Dantzer R, OConnor JC, Lawson MA, et al. (2011) Inflammationassociated depression: From serotonin to kynurenine. Psychoneuroendocrinology 36: 426-436
26. Davidson KW. (2012). Depression, and coronary heart disease. ISRN Cardiology 2012: Article ID 743813
27. Davidson KW, Rieckmann N, Clemow L, et al. (2010) Enhanced depression care for patients with acute coronary syndrome, and persistent depressive symptoms: Coronary psychosocial evaluation studies randomized controlled trial. Archives of Internal Medicine 170: 600-608
28. De Jonge P, Honig A, van Melle J, et al. (2007) Nonresponse to treatment for depression following myocardial infarction: Association with subsequent cardiac events. American Journal of Psychiatry 164: 1371-1378
29. De Jonge P, Rosmalen JGM, Kema IP, et al. (2010) Psychophysiological biomarkers explaining the association between depression, and prognosis in coronary artery patients: A critical review of the literature. Neuroscience & Biobehavioral Reviews 35: 84-90
30. Dekker M, Koper J, Van Aken M, et al. (2008) Salivary cortisol is related to atherosclerosis of carotid arteries. Journal of Clinical Endocrinology, and Metabolism 93: 3741-3747
31. Di Stefano R, Felice F, Pini S, et al. (2014) Impact of depression on circulating endothelial progenitor cells in patients with acute coronary syndromes: A pilot study. Journal of Cardiovascular Medicine 15: 353-359
32. Dinan TG. (2009). Inflammatory markers in depression. Current Opinion in Psychiatry 22: 32-36
33. Dowlati Y, Herrmann N, Swardfager W, et al. (2010) A meta-Analysis of cytokines in major depression. Biological Psychiatry 67: 446-457
34. Duivis HE, de Jonge P, Penninx BW, et al. (2011) Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: Prospective findings from the Heart, and Soul study. American Journal of Psychiatry 168: 913-920
35. Elovainio M, Hurme M, Jokela M, et al. (2012) Indoleamine 2,3-dioxygenase activation, and depressive symptoms: Results from the Young Finns Study. Psychosomatic Medicine 74: 675-681
36. Empana J, Sykes D, Luc G, et al. (2005) Contributions of depressive mood, and circulating inflammatory markers to coronary heart disease in healthy European men. Circulation 111: 2299-2305
37. Ernst E, Hammerschmidt DE, Bagge U, et al. (1987) Leukocytes, and the risk of ischemic diseases. Journal of the American Medical Association 257: 2318-2324
38. Felger JC, and Lotrich FE. (2013). Inflammatory cytokines in depression: Neurobiological mechanisms, and therapeutic implications. Neuroscience 246: 199-229
39. Frasure-Smith N, Lesperance F, Irwin MR, et al. (2009) The relationships among heart rate variability, inflammatory markers, and depression in coronary heart disease patients. Brain, Behavior, and Immunity 23: 1140-1147
40. Freedland KE, and Carney RM. (2013). Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Medicine 11: 131
41. Gehi A, Musselman D, Otte C, et al. (2010) Depression, and platelet activation in outpatients with stable coronary heart disease: Findings from the Heart, and Soul Study. Psychiatry Research 175: 200-204
42. Glassman AH. (2007). Depression, and cardiovascular comorbidity. Dialogues in Clinical Neuroscience 9: 9-17
43. Grebe KM, Takeda K, Hickman HD, et al. (2010) Cutting edge: Sympathetic nervous system increases proinflammatory cytokines, and exacerbates influenza A virus pathogenesis. The Journal of Immunology 184: 540-544
44. Groves J. (2007). Is it time to reassess the BDNF hypothesis of depression? Molecular Psychiatry 12: 1079-1088
45. Gunaratne P, Lloyd AR, and Vollmer-Conna U. (2013). Mood disturbance after infection. Australian, and New Zealand Journal of Psychiatry 47: 1152-1164
46. Harrison NA, Cooper E, Voon V, et al. (2013) Central autonomic network mediates cardiovascular responses to acute inflammation: Relevance to increased cardiovascular risk in depression? Brain, Behavior, and Immunity 31: 189-196
47. Hart BL. (1988). Biological basis of the behavior of sick animals. Neuroscience & Biobehavioral Reviews 12: 123-137
48. Hashimoto K. (2010). Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview, and future directions. Psychiatry, and Clinical Neurosciences 64: 341-357
49. Heeschen C, Dimmeler S, Hamm CW, et al. (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107: 2109-2114
50. Hillebrand S, Gast KB, de Mutsert R, et al. (2013) Heart rate variability, and first cardiovascular event in populations without known cardiovascular disease: Meta-Analysis, and dose-response meta-regression. Europace 15: 742-749
51. Howren MB, Lamkin DM, and Suls J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-Analysis. Psychosomatic Medicine 71: 171-186
52. Huikuri HV, and Stein PK. (2012). Clinical application of heart rate variability after acute myocardial infarction. Frontiers in Physiology 3: 41
53. Joynt KE, Whellan DJ, and OConner CM. (2003). Depression, and cardiovascular disease: Mechanisms of interaction. Biological Psychiatry 54: 248-261
54. Jun TY, Pae CU, Chae JH, et al. (2003) Possible association between-G308A tumour necrosis factor-α gene polymorphism, and major depressive disorder in the Korean population. Psychiatric Genetics 13: 179-181
55. Kannel WB, Anderson K, and Wilson PW. (1992). White blood cell count, and cardiovascular disease. Journal of the American Medical Association 267: 1253-1256
56. Kaptoge S, Di Angelantonio E, Lowe G, et al. (2010) C-reactive protein concentration, and risk of coronary heart disease, stroke, and mortality: An individual participant meta-Analysis. The Lancet 375: 132-140
57. Karg K, Burmeister M, Shedden K, et al. (2011) The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-Analysis revisited: Evidence of genetic moderation. Archives of General Psychiatry 68: 444-454
58. Kemp AH, Quintana DS, Felmingham KL, et al. (2012) Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: Implications for cardiovascular risk. PLoS ONE 7: e30777
59. Kemp AH, Quintana DS, Gray MA, et al. (2010) Impact of depression, and antidepressant treatment on heart rate variability: A review, and metaanalysis. Biological Psychiatry 67: 1067-1074
60. Kermani P, and Hempstead B. (2007). Brain-derived neurotrophic factor: A newly described mediator of angiogenesis. Trends in Cardiovascular Medicine 17: 140-143
61. Kin NW, and Sanders VM. (2006). It takes nerve to tell T, and B cells what to do. Journal of Leukocyte Biology 79: 1093-1104
62. Kleiger RE, Miller JP, Bigger JT Jr, et al. (1987) Decreased heart rate variability, and its association with increased mortality after acute myocardial infarction. The American Journal of Cardiology 59: 256-262
63. Kop WJ, Stein PK, Tracy RP, et al. (2010) Autonomic nervous system dysfunction, and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosomatic Medicine 72: 626-635
64. Korszun A, and Frenneaux MP. (2006). Stress-The battle for hearts, and minds: Links between depression, stress, and ischemic heart disease. Future Cardiology 2: 571-578
65. Kuijpers PM, Hamulyak K, Strik JJ, et al. (2002) Beta-Thromboglobulin, and platelet factor 4 levels in post-myocardial infarction patients with major depression. Psychiatry Research 109: 207-210
66. Ladwig K-H, Marten-Mittag B, Lowel H, et al. (2005) C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: Results from the MONICA-KORA Augsburg Cohort Study 1984-1998. European Heart Journal 26: 2537-2542
67. Lane D, Carroll D, Ring C, et al. (2001) Predictors of attendance at cardiac rehabilitation after myocardial infarction. Journal of Psychosomatic Research 51: 497-501
68. Le Melledo JM, Mahil N, and Baker GB. (2004). Nitric oxide: A key player in the relation between cardiovascular disease, and major depressive disorder? Journal of Psychiatry, and Neuroscience 29: 414-416
69. Lee B-H, Kim H, Park S-H, et al. (2007) Decreased plasma BDNF level in depressive patients. Journal of Affective Disorders 101: 239-244
70. Libby P. (2012). Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 2045-2051
71. Lichtman JH, Froelicher ES, Blumenthal JA, et al. (2014) Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review, and recommendations-A scientific statement from the American Heart Association. Circulation 129: 1350-1369
72. Lipsky RH, and Marini AM. (2007). Brain-derived neurotrophic factor in neuronal survival, and behavior-related plasticity. Annals of the New York Academy of Sciences 1122: 130-143
73. Liu H, Luiten PGM, Eisel ULM, et al. (2013) Depression after myocardial infarction: TNF-α-induced alterations of the blood-brain barrier, and its putative therapeutic implications. Neuroscience & Biobehavioral Reviews 37: 561-572
74. Lopez AD, Mathers CD, Ezzati M, et al. (2006) Global, and regional burden of disease, and risk factors, 2001: Systematic analysis of population health data. The Lancet 367: 1747-1757
75. Lopez-Leon S, Janssens A, Ladd AMGZ, et al. (2007) Meta-Analyses of genetic studies on major depressive disorder. Molecular Psychiatry 13: 772-785
76. Lopresti AL, Hood SD, and Drummond PD. (2013) A review of lifestyle factors that contribute to important pathways associated with major depression: Diet, sleep, and exercise. Journal of Affective Disorders 148: 12-27
77. Luckhoff H, Van Rensburg S, Botha K, et al. (2014) The pro-inflammatory TNFA-308G A (rs1800629) polymorphism is associated with an earlier age at onset in patients with major depressive disorder. Journal of Psychiatry 17: 124
78. Mclean L, Tennant C, Ward C, et al. (2007) Sick at heart? Results of a longitudinal interventional case-control study in to the prothrombotic links between depression, and heart disease. Australian, and New Zealand Journal of Psychiatry 41: A58
79. Maier SF, and Watkins LR. (2010). Role of the medial prefrontal cortex in coping, and resilience. Brain Research 1355: 52-60
80. Malarstig A, Eriksson P, Hamsten A, et al. (2008) Raised interleukin-10 is an indicator of poor outcome, and enhanced systemic inflammation in patients with acute coronary syndrome. Heart 94: 724-729
81. Miller AH, Haroon E, Raison CL, et al. (2013) Cytokine targets in the brain: Impact on neurotransmitters, and neurocircuits. Depression, and Anxiety 30: 297-306
82. Miller AH, Maletic V, and Raison CL. (2009). Inflammation, and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry 65: 732-741
83. Mombouli J-V, and Vanhoutte PM. (1999). Endothelial dysfunction: From physiology to therapy. Journal of Molecular, and Cellular Cardiology 31: 61-74
84. Mulle JG, and Vaccarino V. (2013). Cardiovascular disease, psychosocial factors, and genetics: The case of depression. Progress in Cardiovascular Diseases 55: 557-562
85. Muller N, and Schwarz M. (2007). The immune-mediated alteration of serotonin, and glutamate: Towards an integrated view of depression. Molecular Psychiatry 12: 988-1000
86. Musselman DL, Tomer A, Manatunga AK, et al. (1996) Exaggerated platelet reactivity in major depression. The American Journal of Psychiatry 153: 1313-1317
87. Nahas Z, Marangell LB, Husain MM, et al. (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. The Journal of Clinical Psychiatry 66: 1097-1104
88. Nakahashi T, Fujimura H, Altar CA, et al. (2000) Vascular endothelial cells synthesize, and secrete brain-derived neurotrophic factor. FEBS Letters 470: 113-117
89. Nakatani D, Sato H, Sakata Y, et al. (2005) Influence of serotonin transporter gene polymorphism on depressive symptoms, and new cardiac events after acute myocardial infarction. American Heart Journal 150: 652-658
90. Nemeroff CB, and Goldschmidt-Clermont PJ. (2012). Heartache, and heartbreak-The link between depression, and cardiovascular disease. Nature Reviews Cardiology 9: 526-539
91. Nemeroff CB, and Musselman DL. (2000). Are platelets the link between depression, and ischemic heart disease? American Heart Journal 140: 57-62
92. Neubauer H, Petrak F, Zahn D, et al. (2013) Newly diagnosed depression is associated with increased beta-Thromboglobulin levels, and increased expression of platelet activation markers, and platelet derived CD40-CD40L. Journal of Psychiatric Research 47: 865-871
93. Nijm J, and Jonasson L. (2009). Inflammation, and cortisol response in coronary artery disease. Annals of Medicine 41: 224-233
94. Okada S, Yokoyama M, Toko H, et al. (2012) Brain-derived neurotrophic factor protects against cardiac dysfunction after myocardial infarction via a central nervous system-mediated pathway. Arteriosclerosis, Thrombosis, and Vascular Biology 32: 1902-1909
95. Parker GB, Hilton TM, Walsh WF, et al. (2008) Timing is everything: The onset of depression, and acute coronary syndrome outcome. Biological Psychiatry 64: 660-666
96. Patron E, Messerotti Benvenuti S, Favretto G, et al. (2012) Association between depression, and heart rate variability in patients after cardiac surgery: A pilot study. Journal of Psychosomatic Research 73: 42-46
97. Patterson SM, Matthews KA, Allen MT, et al. (1995) Stress-induced hemoconcentration of blood cells, and lipids in healthy women during acute psychological stress. Health Psychology 14: 319-324
98. Pereira VH, Cerqueira JJ, Palha JA, et al. (2013) Stressed brain, diseased heart: A review on the pathophysiologic mechanisms of neurocardiology. International Journal of Cardiology 166: 30-37
99. Pizzi C, Rutjes AWS, Costa GM, et al. (2011) Meta-Analysis of selective serotonin reuptake inhibitors in patients with depression, and coronary heart disease. American Journal of Cardiology 107: 972-979
100. Poon DC-H, Ho Y-S, Chiu K, et al. (2013) Cytokines: How important are they in mediating sickness? Neuroscience & Biobehavioral Reviews 37: 1-10
101. Quak J, Doornbos B, Roest AM, et al. (2014) Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity, and depressive symptoms? Psychoneuroendocrinology 45: 202-210
102. Raison CL, and Miller AH. (2011). Is depression an inflammatory disorder? Current Psychiatry Reports 13: 467-475
103. Raison CL, and Miller AH. (2013). Malaise, melancholia, and madness: The evolutionary legacy of an inflammatory bias. Brain, Behavior, and Immunity 31: 1-8
104. Raison CL, Dantzer R, Kelley KW, et al. (2010) CSF concentrations of brain tryptophan, and kynurenines during immune stimulation with IFN-Alpha: Relationship to CNS immune responses, and depression. Molecular Psychiatry 15: 393-403
105. Raison CL, Rutherford RE, Woolwine BJ, et al. (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31-41
106. Ramasamy I. (2011). Biochemical markers in acute coronary syndrome. Clinica Chimica Acta 412: 1279-1296
107. Risch N, Herrell R, Lehner T, et al. (2009) Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. Journal of the American Medical Association 301: 2462-2471
108. Ross R. (1999). Atherosclerosis-An inflammatory disease. New England Journal of Medicine 340: 115-126
109. Scherrer JF, Xian H, Bucholz KK, et al. (2003) A twin study of depression symptoms, hypertension, and heart disease in middle-Aged men. Psychosomatic Medicine 65: 548-557
110. Schins A, Honig A, Crijns H, et al. (2003) Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosomatic Medicine 65: 729-737
111. Segerstrom SC, and Miller GE. (2004). Psychological stress, and the human immune system: A meta-Analytic study of 30 years of inquiry. Psychological Bulletin 130: 601-630
112. Serebruany VL, Glassman AH, Malinin AI, et al. (2003) Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: Evidence from recent clinical trials. Blood Coagulation, and Fibrinolysis 14: 563-567
113. Sherwood A, Hinderliter AL, Watkins LL, et al. (2005) Impaired endothelial function in coronary heart disease patients with depressive symptomatology. Journal of the American College of Cardiology 46: 656-659
114. Shimbo D, Rieckmann N, Paulino R, et al. (2006) Relation between C-reactive protein, and depression remission status in patients presenting with acute coronary syndrome. Heart 92: 1316-1318
115. Shimizu E, Hashimoto K, Okamura N, et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 54: 70-75
116. Shlipak MG, Ix JH, Bibbins-Domingo K, et al. (2008) Biomarkers to predict recurrent cardiovascular disease: The Heart, and Soul Study. The American Journal of Medicine 121: 50-57
117. Smith DA, Irving SD, Sheldon J, et al. (2001) Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104: 746-749
118. Sookoian SC, Gonzalez C, and Pirola CJ. (2005). Meta-Analysis on the G-308A tumor necrosis factor α gene variant, and phenotypes associated with the metabolic syndrome. Obesity Research 13: 2122-2131
119. Souverein PC, Berard A, Van Staa TP, et al. (2004) Use of oral glucocorticoids, and risk of cardiovascular, and cerebrovascular disease in a population based case-Control study. Heart 90: 859-865
120. Stapelberg NJ, Hamilton-Craig I, Neumann DL, et al. (2012) Mind, and heart: Heart rate variability in major depressive disorder, and coronary heart disease-A review, and recommendations. Australian, and New Zealand Journal of Psychiatry 46: 946-957
121. Stapelberg NJ, Neumann DL, Shum DH, et al. (2011) A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder, and coronary heart disease. Australian, and New Zealand Journal of Psychiatry 45: 351-369
122. Stein PK, Carney RM, Freedland KE, et al. (2000) Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. Journal of Psychosomatic Research 48: 493-500
123. Steptoe A, Wikman A, Molloy GJ, et al. (2013) Inflammation, and symptoms of depression, and anxiety in patients with acute coronary heart disease. Brain, Behavior, and Immunity 31: 183-188
124. Su S, Miller AH, Snieder H, et al. (2009) Common genetic contributions to depressive symptoms, and inflammatory markers in middle-Aged men: The Twins Heart Study. Psychosomatic Medicine 71: 152-158
125. Suchankova P, Holm G, Traskman-Bendz L, et al. (2013) The +1444CT polymorphism in the CRP gene: A study on personality traits, and suicidal behaviour. Psychiatric Genetics 23: 70-76
126. Task Force of the European Society of Cardiology the North American Society of Pacing (Electrophysiology) (1996) Guidelines: Heart rate variability-standards of measurement, physiological interpretation, and clinical use. European Heart Journal 17: 354-381
127. Taylor CB. (2010). Depression, heart rate related variables, and cardiovascular disease. International Journal of Psychophysiology 78: 80-88
128. Terracciano A, Martin B, Ansari D, et al. (2010) Plasma BDNF concentration, Val66Met genetic variant, and depression-related personality traits. Genes, Brain, and Behavior 9: 512-518
129. Thayer JF, Ahs F, Fredrikson M, et al. (2012) A meta-Analysis of heart rate variability, and neuroimaging studies: Implications for heart rate variability as a marker of stress, and health. Neuroscience & Biobehavioral Reviews 36: 747-756
130. Thayer JF, and Lane R. (2007). The role of vagal function in the risk for cardiovascular disease, and mortality. Biological Psychology 74: 224-242
131. Thayer JF, and Sternberg E. (2006). Beyond heart rate variability. Annals of the New York Academy of Sciences 1088: 361-372
132. Tracey KJ. (2009). Reflex control of immunity. Nature Review Immunology 9: 418-428
133. Van Melle JP, de Jonge P, Honig A, et al. (2007) Effects of antidepressant treatment following myocardial infarction British Journal of Psychiatry 190: 460-466
134. Verma S, Wang C-H, Li S-H, et al. (2002) A self-fulfilling prophecy C-reactive protein attenuates nitric oxide production, and inhibits angiogenesis. Circulation 106: 913-919
135. Vollmer-Conna U. (2001). Acute sickness behaviour: An immune systemto-brain communication? Psychological Medicine 31: 761-767
136. Vollmer-Conna U, Aslakson E, and White PD. (2006). An empirical delineation of the heterogeneity of chronic unexplained fatigue in women. Pharmacogenomics 7: 355-364
137. Von Kanel R, Mills PJ, Fainman C, et al. (2001) Effects of psychological stress, and psychiatric disorders on blood coagulation, and fibrinolysis: A biobehavioral pathway to coronary artery disease? Psychosomatic Medicine 63: 531-544
138. Walker BR. (2007). Glucocorticoids, and cardiovascular disease. European Journal of Endocrinology 157: 545-559
139. Wang Y, Zhao X, ONeil A, et al. (2013) Altered cardiac autonomic nervous function in depression. BMC Psychiatry 13: 187
140. Wei L, MacDonald TM, and Walker BR. (2004). Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Annals of Internal Medicine 141: 764-770
141. Welsh P, Murray HM, Ford I, et al. (2011) Circulating interleukin-10, and risk of cardiovascular events: A prospective study in the elderly at risk. Arteriosclerosis, Thrombosis, and Vascular Biology 31: 2338-2344
142. Whooley MA. (2013). Depression, and cardiovascular disorders. Annual Review of Clinical Psychology 9: 327-354
143. Wilson AG, Symons JA, McDowell TL, et al. (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 94: 3195-3199
144. Wu T, Snieder H, and de Geus E. (2010). Genetic influences on cardiovascular stress reactivity. Neuroscience & Biobehavioral Reviews 35: 58-68
145. Xhyheri B, Manfrini O, Mazzolini M, et al. (2012) Heart rate variability today. Progress in Cardiovascular Diseases 55: 321-331
146. Ziegelstein R, Parakh K, Sakhuja A, et al. (2009) Platelet function in patients with major depression. Internal Medicine Journal 39: 38-43
147. Zorrilla EP, Luborsky L, McKay JR, et al. (2001) The relationship of depression, and stressors to immunological assays: A meta-Analytic review. Brain, Behavior, and Immunity 15: 199-226